Afya Limited (NASDAQ:AFYA – Get Free Report) has been given an average recommendation of “Hold” by the eight research firms that are currently covering the company, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and one has given a buy rating to the company. The average 1-year price objective among analysts that have issued a report on the stock in the last year is $17.30.
Several research firms have recently commented on AFYA. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $22.00 target price (down from $24.50) on shares of Afya in a research note on Wednesday, January 7th. Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a report on Saturday, January 31st. Zacks Research lowered Afya from a “hold” rating to a “strong sell” rating in a research report on Friday, January 9th. UBS Group reissued a “neutral” rating and set a $16.00 price objective (down from $18.00) on shares of Afya in a report on Friday, January 16th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Afya in a research report on Wednesday, January 21st.
View Our Latest Stock Report on AFYA
Hedge Funds Weigh In On Afya
Afya Stock Performance
Shares of Afya stock opened at $13.86 on Monday. The company has a debt-to-equity ratio of 0.21, a current ratio of 0.98 and a quick ratio of 0.98. The firm has a 50 day simple moving average of $14.53 and a 200 day simple moving average of $14.81. Afya has a fifty-two week low of $13.00 and a fifty-two week high of $19.90. The firm has a market cap of $1.30 billion, a P/E ratio of 9.97, a P/E/G ratio of 0.67 and a beta of 0.52.
Afya Company Profile
Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.
At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.
Featured Articles
- Five stocks we like better than Afya
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.
